Circulating activated endothelial cells in systemic lupus erythematosus - Further evidence for diffuse vasculopathy

Citation
R. Clancy et al., Circulating activated endothelial cells in systemic lupus erythematosus - Further evidence for diffuse vasculopathy, ARTH RHEUM, 44(5), 2001, pp. 1203-1208
Citations number
26
Categorie Soggetti
Rheumatology,"da verificare
Journal title
ARTHRITIS AND RHEUMATISM
ISSN journal
00043591 → ACNP
Volume
44
Issue
5
Year of publication
2001
Pages
1203 - 1208
Database
ISI
SICI code
0004-3591(200105)44:5<1203:CAECIS>2.0.ZU;2-6
Abstract
Objective. In flares of systemic lupus erythematosus (SLE), endothelial cel ls (EC; activated by immune stimuli) are potential participants in the infl ammatory processes that contribute to tissue damage. Accordingly, elevated levels of circulating endothelial cells (CEC) may be a marker for vascular injury. This study was undertaken to examine the possibility that stimulate d EC are found in the circulation in patients with active SLE. Methods. The study cohort included 38 patients with SLE and 16 healthy cont rols. Immunostaining was performed on mononuclear isolates, using mouse P1H 12 (endothelial-specific antibody) and rabbit anti-nitrotyrosine (a "footpr int" of a reactive form of nitric oxide [peroxynitrite]). Results. Levels of CEC were significantly higher in patients with active SL E compared with those in healthy controls (mean +/- SEM 32 +/- 7/ml versus 5 +/- 2/ml; P = 0.0028) and were correlated positively with plasma C3a in t hese patients (r = 0.81, P = 0.0008). Furthermore, CEC from these patients expressed an activated phenotype, as indicated by staining for nitrotyrosin e. Conclusion. Elevated levels of CEC observed,in patients with active SLE may represent a marker of endothelial injury. The activated phenotype of these cells suggests that they may be capable of further potentiating vascular i njury by the production of inflammatory and prothrombotic mediators and eng aging in heterotypic aggregation with neutrophils or platelets.